Target intelligence / Profile preview

MicroRNA 4780 (MIR4780 (or hsa-miR-4780))

Target
MIR4780 (or hsa-miR-4780)
Molecular classification
microRNA, Small non-coding RNA, Gene silencer
01

Overview

MicroRNA 4780 is a member of the microRNA class, comprising short (20–24 nucleotides) non-coding RNAs that function in post-transcriptional regulation of gene expression. MicroRNAs are transcribed as primary miRNA transcripts (pri-miRNAs), processed by Drosha and Dicer enzymes to form mature miRNAs. These mature forms are loaded into the RNA-induced silencing complex (RISC), where they bind target mRNAs through partial sequence complementarity—usually in the 3' untranslated region (3' UTR)—resulting in inhibition of translation or destabilization and degradation of the mRNA. The specific targets and functions of microRNA 4780 have not yet been well characterized, but in general, microRNAs play key roles in regulating processes such as cell proliferation, differentiation, apoptosis, and response to environmental stimuli. Dysregulation of microRNAs has been widely implicated in the pathogenesis of diseases including cancer, cardiovascular disease, and inflammation. While microRNAs as a molecular family are of clinical interest for biomarker discovery and therapeutic intervention, there is currently very limited or no published information specific to biological roles, disease connection, or drug interaction for microRNA 4780 itself beyond basic sequence data and RNA class. The entry is correct, but the lack of functional characterization may limit its utility for downstream drug/discovery pipelines at this time.

Other names
hsa-miR-4780MIR4780microRNA 4780
02

Mechanism of action

For mimics/inhibitors of miRNAs: modulation of gene expression via mRNA degradation or translation inhibition

03

Biological functions

Post-transcriptional regulation of gene expressionmRNA destabilizationTranslational inhibition
04

Disease associations

Other (miRNAs are implicated in cancer, cell cycle, apoptosis, etc., but no direct evidence is available specific to microRNA 4780)
05

Safety considerations

Not identified for MIR4780. For miRNA therapies generally: potential for off-target effects and immune responses
06

Interacting drugs

None known specifically for MIR4780. General miRNA-targeting agents (mimics or inhibitors) exist but are not specific for microRNA 4780.
07

Biomarkers

None known that use MIR4780 for patient selection or monitoring

Beyond the preview

Go deeper on MicroRNA 4780 (MIR4780 (or hsa-miR-4780)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4780 (MIR4780 (or hsa-miR-4780)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call